Symptomatic congenital cytomegalovirus infection: Neonatal morbidity and mortality

Pediatric Infectious Disease Journal

Volumn 11, Issue 2, 1992, Pages 93-99

  Boppana, Suresh B ^a   Pass, Robert F ^a   Britt, William J ^a   Stagno, Sergio ^a   Alford, Charles A ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Congenital infection; Cytomegalovirus; Neonatal morbidity

Indexed keywords

ALANINE AMINOTRANSFERASE;

ARTICLE; BRAIN DISEASE; CONGENITAL INFECTION; CYTOMEGALOVIRUS; DISEASE COURSE; FEMALE; HUMAN; HYPERBILIRUBINEMIA; MAJOR CLINICAL STUDY; MALE; MICROCEPHALY; MORBIDITY; MORTALITY; NEWBORN; PRIORITY JOURNAL; SYMPTOMATOLOGY; THROMBOCYTOPENIA;

CYTOMEGALOVIRUS INFECTIONS; FEMALE; HUMAN; INFANT, NEWBORN; MALE; MORBIDITY; PROSPECTIVE STUDIES; STATISTICS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0026572259     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/00006454-199202000-00007     Document Type: Article

References (29)

1. Pass RF. Epidemiology and transmission of cytomegalovirus. J Infect Dis 1985;152:243-56.
2. Hanshaw JB. Congenital cytomegalovirus infection: a Fifteen year perspective. J Infect Dis 1971;123:555-61.
3. Starr JO, Bart RD, Gold E. Inapparent congenital cytomegalovirus infection: clinical and epidemiological characteristics in early infancy. N Engl J Med 1970;282:1075-8.
4. Stern H, Tucker SM. Prospective study of cytomegalovirus infection in pregnancy. Br Med.J 1973;2:268-70.
5. Stagno S, Reynolds DW, Huang ES, et al. Congenital cytomegalovirus infection: occurrence in an immune population. N Engl J Med 1977:296:1254-8.
6. Stagno S. Cytomegalovirus. In: Remington JS, Klein JO, eds. Infectious diseases of the fetus and newborn infant. 3rd ed. Philadelphia: Saunders, 1990:240-81.
7. Stagno S, Pass RF, Dworsky ME, Britt WJ, Alford CA. Congenital and perinatal cytomegalovirus infections: clinical characteristics and pathogenic factors. In: Plotkin SA, Michelson S, Pagano JS, Rapp F, eds. CMV: pathogenesis and prevention of human infection. Birth defects: original article series. New York: Liss, 1984:65-85.
8. McCracken GH, Shinefield HR, Cobb K, et al. Congenital cytomegalic inclusion disease: a longitudinal study of 20 patients. Am J Dis Child 1969;117:522-39.
9. Pass RF, Stagno S, Meyers GJ, et al. Outcome of symptomatic congenital cytomegalovirus infection: results of long-term longitudinal follow-up. Pediatrics 1980;66:758-62.
10. Conboy TJ, Pass RF, Stagno S, et al. Early clinical manifestations and intellectual outcome with symptomatic congenital cytomegalovirus infection. J Pediatr 1987;111:343-8.
11. Elek SD, Stern H. Development of vaccine against mental retardation caused bv cytomegalovirus. Lancet 1974;1:1-3.
12. Weller TH, Hanshaw JB. Virologic and clinical observations on cytomegalic inclusion disease. N Engl J Med 1962;266:1233-44.
13. Berenberg W, Nankervis G. Long term follow-up of cytomegalic inclusion disease of infancy. Pediatrics 1970;37:403-10.
14. MacDonald H, Tobin JOH. Congenital cytomegalovirus infection: a collaborative study on epidemiological, clinical and laboratory findings. Dev Med Child Neurol 1978;20:471-82.
15. Williamson WD, Desmond MM, LaFevers N, et al. Symptomatic congenital cytomegalovirus infection: disorders of language, learning and hearing. Am J Dis Child 1982;136:902-5.
16. Bale JF Jr. Blackman JA, Sato Y. Outcome in children with symptomatic congenital cytomegalovirus infection. J Child Neurol 1990;4:131-6.
17. SAS Institute Inc. SAS/STAT" guide for personal computers. Version 6.03 edition. Cary, NC: SAS Institute, 1987.
18. Hollingshead AB. Two factor index for social position. New Haven, CT: Yale University, 1957.
19. Lubchenko LO, Hansman C, Boyd E. Intrauterine growth in length and head circumference as estimated from live births at gestational ages from 26 to 42 weeks. Pediatrics 1966;37:403- 11.
20. Stagno S, Reynolds DW, Amos CA, et al. Auditory and visual defects resulting from symptomatic and subclinical congenital cvtomegaloviral and Toxoplasma infection. Pediatrics 1977;59:669-78.
21. Picton TW, Woods DL, Braun J, et al. Evoked potential audiometry. J Otolaryngol 1977;6:90-4.
22. Naidoo BT. The cerebrospinal fluid in the healthy newborn infant. S Afr Med J 1968;42:933-5.
23. Dahle AJ, McCollister FP, Stagno S, et al. Progressive hearing impairment in children with congenital cytomegalovirus infection. J Speech Hearing Dis 1979;44:220-9.
24. Bale JF Jr., Sato Y, Eisert D. Progressive postnatal subependymal necrosis in an infant with congenital cytomegalovirus infection. Pediatr Neurol 1986;2:367-70.
25. Dworsky ME, Pass RF, Stagno S, et al. Therapeutic approaches to the control of cytomegalovirus infections. In: Plotikin SA, Michelson S, Pagano JS, Rapp F, eds. CMV: pathogenesis and prevention of human infection. Birth defects: original article series. New York: Liss, 1984:65-85.
26. Alford CA. Chronic intrauterine and perinatal infections. In: Galasso GJ, Buchanan RA, eds. Antiviral agents and viral diseases of man. 2nd ed. New York: Raven Press, 1984:483-86.
27. Meyers.JD. Prevention and treatment of cytomegalovirus infections with interferon and immune globulins. Infection 1984;12:143-50.
28. Collaborative DHPG treatment study group. Treatment of serious cytomegalovirus infections with 9-l,3-dihydroxy-2-pro- poxymethyllguanine in patients with AIDS and other immunodeficiencies. N Engl J Med 1986:801-5.
29. Hocker JR, Cook LN, Adams G, Rabalais GP. Ganciclovir therapv of congenital cvtomegalovirus pneumonia. Pediatr Infect Dis J 1990;9:743-5.